Tonghua Dongbao Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥15.12 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	42.89
Forward PE	21.44
Price to Sales TTM	CN¥6.22
Price to Book MRQ	CN¥2.34
Enterprise to Revenue	6.23
Enterprise to EBITDA	19.72

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	14.04%
Operating Margin	18.56%
Return on Assets TTM	4.87%
Return on Equity TTM	5.14%

Income Statement

Revenue TTM	CN¥2,431,641,600
Revenue per Share TTM	CN¥1.14
Quarterly Revenue Growth	-2.40%
Gross Profit TTM	CN¥1,884,362,752
EBITDA	CN¥1,591,953,533
Net Income to Common TTM	CN¥341,308,128
Diluted EPS TTM	CN¥0.18
Quarterly Earnings Growth YoY	-40.40%

Balance Sheet

Total Cash MRQ	CN¥372,825,312
Total Cash per Share MRQ	CN¥0.19
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	7.66
Current Ratio MRQ	4.30
Book Value per Share MRQ	CN¥3.30

Cash Flow

Operating Cash Flow TTM	CN¥613,506,304
Levered Free Cash Flow TTM	CN¥-67,688,912

600867 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,958,540,032
Float Shares	1,146,964,548
Avg 10 Volume	9,373,280
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.72%
% Held by Institutions	18.67%

Stock Price Summary

Beta	0.27
Fifty Two Week Low	CN¥7.02
Fifty Two Week High	CN¥11.09
Fifty Two Week Change	-19.17%
Day 50 MA	CN¥8.17
Day 200 MA	CN¥8.53

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.00
Forward Annual Dividend Yield	12.95%
Trailing Annual Dividend Rate	CN¥0.25
Trailing Annual Dividend Yield	3.24%
Payout Ratio	138.89%
Dividend Date
Ex Dividend Date	2024-05-23
Last Split Factor
Last Split Date	2018-05-25